Stay Awesome
Pertussis
Find most of the information you need in these resources
Always refer to your local signed PGD's in practice, and remember the Green Book takes priority over the SPmC - and sometimes WHO takes priority over the Green Book! They don't always say the same!
Keeping up to date: Things to know in practice currently:
26th June 2025: New figures released today in the vaccine uptake data by UKHSA show a significant and sustained increase in the number of pregnant women coming forward for the whooping cough vaccine. YAY!!! The latest data reveals a consistent seven-month upward trend in maternal pertussis vaccination rates. The rates climbed from 59.0% in May 2024 to nearly 73% in March this year. Uptake rates are now almost as high as the peak at the start of the programme.
10th June 2025: The Pertussis Green Book chapter has been updated So has the PGD template for Hexavalent vaccine DTaP/IPV/Hib/HepB.
2nd June 2025: This guidance got an update: "Hexavalent DTaP/IPV/Hib/HepB combination vaccine: information for healthcare practitioners". As did this page (Hexavalent combination vaccine: programme guidance) in general.
29th May 2025: More resources - an updated slideset for the hexavalent programme. To help with understanding the changes in the programme from July 2025.
24th April 2025: Quarterly pertussis vaccine coverage data released. Pleasing to see that coverage has consistently increased over the preceding 8 months although still hovering around the 68% uptake mark. So, onwards and upwards!
Reminders:
Acellular vaccine, part of DTaP/IPV and Tdap/IPV
Maternal dose 16 weeks+ of pregnancy
UK childhood schedule (Infanrix/Vaxellis): 2, 3, 4 months, 18m (DOB depending) + 3y 4m booster
Repevax is current UK childhood brand (was Boostrix-IPV prior to Jan 2025). Adacel for pregnant ladies from July 2024 (due to not containing polio but the others can be given for example if allergies to the others OR if polio indicated e.g. for travel or outbreaks). See letter for more info.
Store at 2–8°C; IM injection
Have YOU checked your own vaccine status as a HCP?
Useful resources
Want to geek out? Go deeper here:
7th April 2025: New antibody research sparks hope for better whooping cough vaccines
4th Dec 2024: Intranasal pertussis vaccine? BPZE1 is designed to overcome deficiencies of current pertussis vaccines, including poor durability of protection and failure to prevent nasopharyngeal B. pertussis colonisation that leads to escape mutants and transmission to vulnerable infants. Looks set to be entering phase 3 trials in 2025...
This article about Pertussis uptake was published in the BMJ on 29th August 2024. Here's an extract that forms a good reflection opportunity: "Ongoing analysis of data from England shows that whooping cough vaccine, when given at the right time in pregnancy, provides 92% protection against infant death. Yet its uptake in England, from a high of 72.6% in March 2017, has now declined to 58.9%". We MUST get this higher!!!
Useful and informative TOP TIPS article from July 2024 emphasising some key points about Pertussis vaccination and also management of the disease.
What is pertussis anyway?
Caused by Bordetella pertussis, this highly contagious bacterial infection leads to intense coughing fits. It’s especially dangerous in babies and can cause pneumonia, seizures, and death. In 2018, there were more than 151 000 cases of pertussis globally.
What happens If you catch it?
Starts like a cold, then progresses to severe bouts of coughing (often with a “whoop” sound). Vomiting after coughing is common. Illness can last weeks to months—“the 100-day cough.” Some babies who get pertussis won’t cough at all. Instead, they will simply stop breathing or suffer with apnoea spells.
How does It Spread?
Airborne droplets from coughing or sneezing. Easily passed between close contacts. People with pertussis are most contagious up to about 3 weeks after the cough begins,
Does getting pertussis make you Immune?
Not for long. Immunity from infection or vaccination wanes over time—boosters are essential to maintain protection.
Can it be treated?
Yes—antibiotics (usually macrolides) can shorten infectious period, especially if started early. Supportive care for infants often involves hospitalisation.
Who’s most at risk?
Infants under 6 months (especially before primary doses), pregnant people, healthcare workers and carers of young babies, and adolescents and adults with waning immunity. The disease is most dangerous in infants under 3 months old, and is a significant cause of disease and death in this age group.
Top reasons to encourage vaccination:
Prevents infant hospitalisation and death
Part of UK maternal and childhood schedule
Boosters protect adults and reduce spread to babies
Required in many healthcare roles
Since the introduction of pertussis vaccination in pregnancy, from 2013 to the end of June 2024, there have been 30 deaths in babies with confirmed pertussis who were all too young to be fully protected by infant vaccination. Sadly, this includes the 9 deaths in infants who had contracted pertussis between January and July 2024. Of the 30 infants that died, 24 had mothers who were not vaccinated in pregnancy.
On the 8th August 2024 a 10th Baby died of pertussis in the UK. Also born to an unvaccinated mother. 10,000 cases had been reported at this point since the outbreak that began in November 2023 (although due to under-reporting is probably WAY higher). So sad.
